- Home
- SERA
as 01-21-2025 4:00pm EST
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | SALT LAKE CITY |
| Market Cap: | 208.7M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 153.6K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.99 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.98 - $12.36 | Next Earning Date: | 03-19-2025 |
| Revenue: | $94,000 | Revenue Growth: | -71.52% |
| Revenue Growth (this year): | -63.33% | Revenue Growth (next year): | 4263.64% |
Stock Insider Trading Activity of Sera Prognostics Inc. (SERA)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Jackson Benjamin | SERA | General Counsel | Jan 10 '25 | Sell | $7.00 | 29,591 | $201,133.27 | 129,704 | |
| Aerts Austin | SERA | Chief Financial Officer | Jan 10 '25 | Sell | $8.06 | 2,431 | $19,593.86 | 283,325 | |
| Phillips Joshua | SERA | Director | Jan 10 '25 | Sell | $6.97 | 34,211 | $230,468.54 | 7,074 | |
| Mirza Mansoor Raza | SERA | Director | Jan 6 '25 | Sell | $7.69 | 100 | $769.00 | 6,536 | |
| Lindgardt Zhenya | SERA | Chief Executive Officer | Dec 10 '24 | Sell | $7.41 | 26,224 | $194,319.84 | 793,534 | |
| Aerts Austin | SERA | Chief Financial Officer | Dec 10 '24 | Sell | $7.41 | 5,730 | $42,459.30 | 283,325 | |
| Mirza Mansoor Raza | SERA | Director | Dec 6 '24 | Sell | $7.12 | 93 | $662.16 | 6,536 | |
| Boniface John J. | SERA | Chief Scientific Officer | Nov 11 '24 | Sell | $7.32 | 4,727 | $34,601.64 | 125,120 | |
| Lindgardt Zhenya | SERA | Chief Executive Officer | Nov 11 '24 | Sell | $7.32 | 12,075 | $88,389.00 | 793,534 | |
| Kearney Paul | SERA | Chief Data Officer | Nov 11 '24 | Sell | $7.32 | 4,078 | $29,850.96 | 176,889 |
Latest Sera Prognostics Inc. News
SERA Breaking Stock News: Dive into SERA Ticker-Specific Updates for Smart Investing
PR Newswire
16 days ago
Sera Prognostics to Present at 43rd Annual J.P. Morgan Healthcare Conference
Simply Wall St.
a month ago
With 40% stake, Sera Prognostics, Inc. (NASDAQ:SERA) seems to have captured institutional investors' interest
PR Newswire
2 months ago
Sera Prognostics to Present PRIME Study Results at 2025 SMFM Pregnancy Meeting
PR Newswire
2 months ago
Sera Prognostics to Present at Piper Sandler 36th Annual Healthcare Conference
Fortune
2 months ago
5 investing trends for 2025—and 15 stocks to help you bet on them
PR Newswire
2 months ago
Sera Prognostics to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Simply Wall St.
2 months ago
Sera Prognostics (NASDAQ:SERA) Is In A Strong Position To Grow Its Business
Simply Wall St.
2 months ago
Sera Prognostics Third Quarter 2024 Earnings: Misses Expectations
Compare SERA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SERA Sera Prognostics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.